Planet 13 Holdings (PLNH) Net Equity Issued and Repurchased (2024)
Planet 13 Holdings' (PLNH) quarterly Net Equity Issued and Repurchased came in at -$1.0 in Q4 2024, up 100.0% on a QoQ basis from -$51648.0 in Q2 2024.
Planet 13 Holdings (PLNH) Net Equity Issued and Repurchased (2024) Analysis & Trends
Planet 13 Holdings (PLNH) has 1 years of Net Equity Issued and Repurchased data on file, last reported at -$1.0 in Q4 2024.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$1.0 in Q4 2024; TTM through Sep 2025 was -$1.0, a 100.0% decrease from a year earlier, with the FY2024 full-year figure at $9.9 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q4 2024 stood at -$1.0, up from -$51648.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for PLNH reached as high as $9.9 million in Q1 2024 and fell as low as -$51648.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.00 |
| Dec 31, 2024 | -1.00 |
| Jun 30, 2024 | -51,648.00 |
| Jun 30, 2024 | -51,648.00 |
| Mar 31, 2024 | 9.91 Mn |
| Mar 31, 2024 | 9.91 Mn |